You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The effort will compare clinical sequencing strategies and explore best practices for educating participants and applying the results to patient care.
The actual match rate is significantly higher than the 10 percent rate the researchers anticipated they would see when the study began in 2017.
In the hunt for an antigen in solid tumors that CAR T cells can target, researchers demonstrate the safety and efficacy profile of two such agents in early studies.
